PIV5 M protein interaction with host protein angiomotin-like 1

Virology

Volumn 397, Issue 1, 2010, Pages 155-166

  Pei, Zifei ^a   Bai, Yuting ^a   Schmitt, Anthony P ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

AmotL1; Angiomotin like 1; Matrix protein; Mumps virus; Nipah virus; Parainfluenza virus 5; Paramyxovirus; PIV5; Virus assembly; Virus budding

Indexed keywords

AMINO ACID; ANGIOMOTIN LIKE 1 PROTEIN; CELL PROTEIN; GAG PROTEIN; M PROTEIN; POLYPEPTIDE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MAMMAL CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PARAINFLUENZA VIRUS; PARAINFLUENZA VIRUS 5; PARAMYXOVIRUS; PLASMID; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; RNA VIRUS INFECTION; SCREENING; VIRION; YEAST;

HOST-PATHOGEN INTERACTIONS; HUMANS; MEMBRANE PROTEINS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; RESPIROVIRUS; TWO-HYBRID SYSTEM TECHNIQUES; VIRAL MATRIX PROTEINS; VIRUS ASSEMBLY;

MAMMALIA; MUMPS VIRUS; NIPAH VIRUS; PARAINFLUENZA VIRUS; PARAMYXOVIRIDAE;

EID: 73949100601     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.11.002     Document Type: Article

References (64)

1. Accola M.A., Strack B., and Göttlinger H.G. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J. Virol. 74 12 (2000) 5395-5402
2. Bieniasz P.D. Late budding domains and host proteins in enveloped virus release. Virology 344 1 (2005) 55-63
3. Blau D.M., and Compans R.W. Entry and release of measles virus are polarized in epithelial cells. Virology 210 1 (1995) 91-99
4. Boulan E.R., and Sabatini D.D. Asymmetric budding of viruses in epithelial monlayers: a model system for study of epithelial polarity. Proc. Natl. Acad. Sci. U.S.A. 75 10 (1978) 5071-5075
5. Bratt A., Wilson W.J., Troyanovsky B., Aase K., Kessler R., Van Meir E.G., Holmgren L., and Meir E.G. Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains. Gene 298 1 (2002) 69-77
6. Bratt A., Birot O., Sinha I., Veitonmäki N., Aase K., Ernkvist M., and Holmgren L. Angiomotin regulates endothelial cell-cell junctions and cell motility. J. Biol. Chem. 280 41 (2005) 34859-34869
7. Burke E., Dupuy L., Wall C., and Barik S. Role of cellular actin in the gene expression and morphogenesis of human respiratory syncytial virus. Virology 252 1 (1998) 137-148
8. Calistri A., Salata C., Parolin C., and Palu G. Role of multivesicular bodies and their components in the egress of enveloped RNA viruses. Rev. Med. Virol. 19 1 (2009) 31-45
9. Chen B.J., and Lamb R.A. Mechanisms for enveloped virus budding: can some viruses do without an ESCRT?. Virology 372 2 (2008) 221-232
10. Chen C., Vincent O., Jin J., Weisz O.A., and Montelaro R.C. Functions of early (AP-2) and late (AIP1/ALIX) endocytic proteins in equine infectious anemia virus budding. J. Biol. Chem. 280 49 (2005) 40474-40480
11. Ciancanelli M.J., and Basler C.F. Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization. J. Virol. 80 24 (2006) 12070-12078
12. Craven R.C., Harty R.N., Paragas J., Palese P., and Wills J.W. Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras. J. Virol. 73 4 (1999) 3359-3365
13. Demirov D.G., Ono A., Orenstein J.M., and Freed E.O. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc. Natl. Acad. Sci. U.S.A. 99 2 (2002) 955-960
14. Ernkvist M., Aase K., Ukomadu C., Wohlschlegel J., Blackman R., Veitonmäki N., Bratt A., Dutta A., and Holmgren L. p130-angiomotin associates to actin and controls endothelial cell shape. FEBS J. 273 9 (2006) 2000-2011
15. Ernkvist M., Birot O., Sinha I., Veitonmaki N., Nyström S., Aase K., and Holmgren L. Differential roles of p80- and p130-angiomotin in the switch between migration and stabilization of endothelial cells. Biochim. Biophys. Acta 1783 3 (2008) 429-437
16. Freed E.O. Viral late domains. J. Virol. 76 10 (2002) 4679-4687
17. Freed E.O. The HIV-TSG101 interface: recent advances in a budding field. Trends Microbiol. 11 2 (2003) 56-59
18. Fujii K., Hurley J.H., and Freed E.O. Beyond Tsg101: the role of Alix in 'ESCRTing' HIV-1. Nat. Rev. Microbiol. 5 12 (2007) 912-916
19. Gagne V., Moreau J., Plourde M., Lapointe M., Lord M., Gagnon E., and Fernandes M.J. Human angiomotin-like 1 associates with an angiomotin protein complex through its coiled-coil domain and induces the remodeling of the actin cytoskeleton. Cell Motil. Cytoskeleton 66 9 (2009) 754-768
20. Giuffre R.M., Tovell D.R., Kay C.M., and Tyrrell D.L. Evidence for an interaction between the membrane protein of a paramyxovirus and actin. J. Virol. 42 3 (1982) 963-968
21. Harty R.N. No exit: targeting the budding process to inhibit filovirus replication. Antiviral Res. 81 3 (2009) 189-197
22. Harty R.N., Brown M.E., Wang G., Huibregtse J.M., and Hayes F.P. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc. Natl. Acad. Sci. U.S.A. 97 25 (2000) 13871-13876
23. He B., Lin G.Y., Durbin J.E., Durbin R.K., and Lamb R.A. The SH integral membrane protein of the paramyxovirus simian virus 5 is required to block apoptosis in MDBK cells. J. Virol. 75 9 (2001) 4068-4079
24. He B., Paterson R.G., Stock N., Durbin J.E., Durbin R.K., Goodbourn S., Randall R.E., and Lamb R.A. Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-beta induction and interferon signaling. Virology 303 1 (2002) 15-32
25. Holmgren L., Ambrosino E., Birot O., Tullus C., Veitonmäki N., Levchenko T., Carlson L.M., Musiani P., Iezzi M., Curcio C., Forni G., Cavallo F., and Kiessling R. A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. Proc. Natl. Acad. Sci. U.S.A. 103 24 (2006) 9208-9213
26. Huang H., Lu F.I., Jia S., Meng S., Cao Y., Wang Y., Ma W., Yin K., Wen Z., Peng J., Thisse C., Thisse B., and Meng A. Amotl2 is essential for cell movements in zebrafish embryo and regulates c-Src translocation. Development 134 5 (2007) 979-988
27. Irie T., Shimazu Y., Yoshida T., and Sakaguchi T. The YLDL sequence within sendai virus M protein is critical for budding of virus-like particles and interacts with Alix/AIP1 independently of C protein. J. Virol. 81 5 (2006) 2263-2273
28. Lamb R.A., Mahy B.W., and Choppin P.W. The synthesis of sendai virus polypeptides in infected cells. Virology 69 1 (1976) 116-131
29. Levchenko T., Aase K., Troyanovsky B., Bratt A., and Holmgren L. Loss of responsiveness to chemotactic factors by deletion of the C-terminal protein interaction site of angiomotin. J. Cell. Sci. 116 Pt 18 (2003) 3803-3810
30. Levchenko T., Bratt A., Arbiser J.L., and Holmgren L. Angiomotin expression promotes hemangioendothelioma invasion. Oncogene 23 7 (2004) 1469-1473
31. Levchenko T., Veitonmäki N., Lundkvist A., Gerhardt H., Ming Y., Berggren K., Kvanta A., Carlsson R., and Holmgren L. Therapeutic antibodies targeting angiomotin inhibit angiogenesis in vivo. FASEB J. 22 3 (2008) 880-889
32. Li F., Chen C., Puffer B.A., and Montelaro R.C. Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication. J. Virol. 76 4 (2002) 1569-1577
33. Li M., Schmitt P.T., Li Z., McCrory T.S., He B., and Schmitt A.P. Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J. Virol. 83 14 (2009) 7261-7272
34. Martin-Serrano J. The role of ubiquitin in retroviral egress. Traffic 8 10 (2007) 1297-1303
35. Martin-Serrano J., Yarovoy A., Perez-Caballero D., Bieniasz P.D., and Yaravoy A. Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc. Natl. Acad. Sci. U.S.A. 100 21 (2003) 12414-12419
36. Martin-Serrano J., Eastman S.W., Chung W., and Bieniasz P.D. HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. J. Cell Biol. 168 1 (2004) 89-101
37. Michel D., Arsanto J.P., Massey-Harroche D., Béclin C., Wijnholds J., and Le Bivic A. PATJ connects and stabilizes apical and lateral components of tight junctions in human intestinal cells. J. Cell. Sci. 118 Pt 17 (2005) 4049-4057
38. Munshi U.M., Kim J., Nagashima K., Hurley J.H., and Freed E.O. An Alix fragment potently inhibits HIV-1 budding: characterization of binding to retroviral YPXL late domains. J. Biol. Chem. 282 6 (2006) 3847-3855
39. Nishimura M., Kakizaki M., Ono Y., Morimoto K., Takeuchi M., Inoue Y., Imai T., and Takai Y. JEAP, a novel component of tight junctions in exocrine cells. J. Biol. Chem. 277 7 (2002) 5583-5587
40. Niwa H., Yamamura K., and Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108 2 (1991) 193-199
41. Orvell C. Structural polypeptides of mumps virus. J. Gen. Virol. 41 3 (1978) 527-539
42. Pantua H.D., McGinnes L.W., Peeples M.E., and Morrison T.G. Requirements for the assembly and release of Newcastle disease virus-like particles. J. Virol. 80 22 (2006) 11062-11073
43. Parent L.J., Bennett R.P., Craven R.C., Nelle T.D., Krishna N.K., Bowzard J.B., Wilson C.B., Puffer B.A., Montelaro R.C., and Wills J.W. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J. Virol. 69 9 (1995) 5455-5460
44. Patch J.R., Han Z., McCarthy S.E., Yan L., Wang L.F., Harty R.N., and Broder C.C. The YPLGVG sequence of the Nipah virus matrix protein is required for budding. Virol. J. 5 1 (2008) 137
45. Perez M., Craven R.C., and de la Torre J.C. The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc. Natl. Acad. Sci. U.S.A. 100 22 (2003) 12978-12983
46. Pornillos O.W., Alam S.L., Davis D.R., and Sundquist W.I. Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. Nat. Struct. Biol. 9 11 (2002) 812-817
47. Randall R.E., Young D.F., Goswami K.K., and Russell W.C. Isolation and characterization of monoclonal antibodies to simian virus 5 and their use in revealing antigenic differences between human, canine and simian isolates. J. Gen. Virol. 68 Pt 11 (1987) 2769-2780
48. Schmitt A.P., and Lamb R.A. Escaping from the cell: assembly and budding of negative-strand RNA viruses. Curr. Top. Microbiol. Immunol. 283 (2004) 145-196
49. Schmitt A.P., Leser G.P., Waning D.L., and Lamb R.A. Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J. Virol. 76 8 (2002) 3952-3964
50. Schmitt A.P., Leser G.P., Morita E., Sundquist W.I., and Lamb R.A. Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J. Virol. 79 5 (2005) 2988-2997
51. Shimono A., and Behringer R.R. Angiomotin regulates visceral endoderm movements during mouse embryogenesis. Curr. Biol. 13 7 (2003) 613-617
52. Shin K., Straight S., and Margolis B. PATJ regulates tight junction formation and polarity in mammalian epithelial cells. J. Cell Biol. 168 5 (2005) 705-711
53. Stallcup K.C., Raine C.S., and Fields B.N. Cytochalasin B inhibits the maturation of measles virus. Virology 124 1 (1983) 59-74
54. Studier F.W. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 41 1 (2005) 207-234
55. Sugahara F., Uchiyama T., Watanabe H., Shimazu Y., Kuwayama M., Fujii Y., Kiyotani K., Adachi A., Kohno N., Yoshida T., and Sakaguchi T. Paramyxovirus Sendai virus-like particle formation by expression of multiple viral proteins and acceleration of its release by C protein. Virology 325 1 (2004) 1-10
56. Sugihara-Mizuno Y., Adachi M., Kobayashi Y., Hamazaki Y., Nishimura M., Imai T., Furuse M., and Tsukita S. Molecular characterization of angiomotin/JEAP family proteins: interaction with MUPP1/Patj and their endogenous properties. Genes Cells 12 4 (2007) 473-486
57. Takimoto T., and Portner A. Molecular mechanism of paramyxovirus budding. Virus Res. 106 2 (2004) 133-145
58. Takimoto T., Murti K.G., Bousse T., Scroggs R.A., and Portner A. Role of matrix and fusion proteins in budding of Sendai virus. J. Virol. 75 23 (2001) 11384-11391
59. Troyanovsky B., Levchenko T., Månsson G., Matvijenko O., and Holmgren L. Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J. Cell Biol. 152 6 (2001) 1247-1254
60. Ulloa L., Serra R., Asenjo A., and Villanueva N. Interactions between cellular actin and human respiratory syncytial virus (HRSV). Virus Res. 53 1 (1998) 13-25
61. Wells C.D., Fawcett J.P., Traweger A., Yamanaka Y., Goudreault M., Elder K., Kulkarni S., Gish G., Virag C., Lim C., Colwill K., Starostine A., Metalnikov P., and Pawson T. A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells. Cell 125 3 (2006) 535-548
62. Yuan B., Campbell S., Bacharach E., Rein A., and Goff S.P. Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses. J. Virol. 74 16 (2000) 7250-7260
63. Yuan B., Li X., and Goff S.P. Mutations altering the moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle. EMBO J. 18 17 (1999) 4700-4710
64. Zheng Y., Vertuani S., Nystrom S., Audebert S., Meijer I., Tegnebratt T., Borg J.P., Uhlen P., Majumdar A., and Holmgren L. Angiomotin-like protein 1 controls endothelial polarity and junction stability during sprouting angiogenesis. Circ. Res. 105 3 (2009) 260-270